Fundraising Fox
iBionext
Venture studioParis · Pre-Seed–Growth · 4 people tracked
Find your way into iBionext
Sign up to see every warm intro you have to iBionext
- Paths you didn't know you had: your email and LinkedIn already hold routes to the iBionext team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
iBionext is France's first venture studio in the health sector, operating a three-stage 'Spot, Boost and Grow' model. It sources breakthrough health-tech technologies from a proprietary scientific and academic network, working with founders until they are ready to become high-potential startups (Spot). It then creates and funds selected startups, ensuring sufficient financial resources and operational support (Boost), before financing growth and providing its network to help companies become leaders and pursue exit strategies (Grow). The approach aims to reduce operational risk and build large companies on the basis of disruptive science and technology.
Source: firm website, verified Sep 27, 2026.
Team · 4 people
from the firm's website & public directories
What they invest in
from 2 of 7 portfolio companiesAI & Machine Learning ×1Deep Tech ×1Digital Health ×1Hardware ×1Healthtech ×1Medical Devices ×1Semiconductors ×1
HQs:France×2
Investments · 7 tracked
founders shown can be your intro path
Prophesee develops neuromorphic vision systems using event-based sensors and AI algorithms inspired by human vision, enabling applications in industrial automation, aerospace and defense, autonomous systems, and medical devices.
AI & Machine LearningDeep TechHardwareSemiconductorsParis, FR
Luca VerreinJean Ferré(Chief Executive Officer)in
Co-investorsEuropean Investment BankIntel CapitalSupernova Invest360 CapitalAurum Venture PartnersBosch Ventures+3 more
Tilak Healthcare develops OdySight®, a prescription-based medical mobile app that combines clinically validated vision tests with video game elements to remotely monitor visual parameters in patients with chronic retinal and macular diseases.
Digital HealthHealthtechMedical DevicesParis, FR
Edouard GasserinJosé-Alain Sahel(Co-founder)Jean-François GIRMENS(Founder)in
Co-investorsAdelieCAP HORN VCElaia
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
BrainEverChronolifeGrAI Matter LabsT-HeartTilak
Exits · 1
1 acquisitionsGrAI Matter Labsacq. by Snap Inc.
Portfolio news
latest coverage across their companiesProphesee · prophesee.ai · Jun 15, 2026
Frequently asked questions
- How many investments has iBionext made?
- iBionext has 7 tracked investments, 1 of which have exited.
- What stage does iBionext invest at?
- iBionext invests at the Pre-Seed, Seed, Series A, Growth stages.
- What sectors does iBionext focus on?
- iBionext focuses on AI & Machine Learning, Biotech, Deep Tech, Digital Health, Healthtech, Medical Devices.
- Where is iBionext located?
- iBionext is headquartered in Paris, FR.
- Does iBionext lead rounds?
- Yes, iBionext leads investment rounds.
- Who does iBionext co-invest with?
- iBionext most often shares deals with 360 Capital, Aurum Venture Partners, Bosch Ventures, among 5 tracked co-investors.
Media · Podcasts & interviews
featuring the teamInterview avec Bernard Gilly, fondateur, iBioNext
Forbes France · Bernard Gilly
Les Trophées #LetsgoFrance 2018 - Alexia Perouse, iBionext
PwC France · Alexia Perouse · youtube.com
Images
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
Artesian is a deep tech and hardware venture capital investor that builds funds around specific institutional backers — governments, corporations, universities, industry bodies and super funds — to pursue both financial returns and strategic outcomes in critical industries.